STOCK TITAN

Shattuck Labs (STTK) CTO exercises options and makes small 10b5-1 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Shattuck Labs Chief Technical Officer Abhinav A. Shukla reported option exercises and a small share sale in Common Stock. He exercised options to acquire 12,563 shares at $3.57 per share in two transactions and now holds 98,533 Common shares directly.

Shukla also sold 410 shares of Common Stock at a weighted average price of $7.01 per share, with individual sale prices ranging from $7.00 to $7.03. The sale was made under a pre-arranged Rule 10b5-1 trading plan designed to fund option exercise costs and related tax withholding. Following these transactions, he also holds 14,140 stock options with a $3.57 exercise price, expiring on January 25, 2033.

Positive

  • None.

Negative

  • None.
Insider Shukla Abhinav A.
Role Chief Technical Officer
Sold 410 shs ($3K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 12,153 $0.00 --
Exercise Common Stock 12,153 $3.57 $43K
Exercise Stock Option (Right to Buy) 410 $0.00 --
Exercise Common Stock 410 $3.57 $1K
Sale Common Stock 410 $7.01 $3K
Holdings After Transaction: Stock Option (Right to Buy) — 14,140 shares (Direct, null); Common Stock — 98,533 shares (Direct, null)
Footnotes (1)
  1. Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026. The plan is intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding associated with option exercises under the plan. Under the procedures of the administering broker, acquired shares are first sold to fund the aggregate exercise price and estimated tax withholding with respect to all possible option exercises in a particular order under the plan and only once fully funded will acquired shares be held by the Reporting Person. This transaction represents the final sale of shares needed to fully fund the exercise price and estimated tax withholding for the option exercises under this order of the plan and the remaining shares acquired upon exercise under this order will be held by the Reporting Person. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.000 to $7.030, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option represents a right to purchase a total of 52,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
Options exercised 12,563 shares Common Stock acquired via option exercises at $3.57 per share
Exercise price $3.57/share Stock Option (Right to Buy) conversion or exercise price
Shares sold 410 shares Open-market sale of Common Stock on 2026-07-02
Weighted average sale price $7.01/share Sales executed between $7.00 and $7.03 per share
Shares after transactions 98,533 shares Common Stock directly owned following reported transactions
Options remaining 14,140 options Stock Option (Right to Buy) balance after exercises
Option grant size 52,200 shares Total shares covered by referenced option grant, subject to vesting
Option expiration January 25, 2033 Expiration date of the Stock Option (Right to Buy)
Rule 10b5-1 trading plan regulatory
"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above is a weighted average price. The shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... conversion or exercise price $3.5700 ... underlying Common Stock"
vesting financial
"one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
estimated tax withholding financial
"intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding..."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did Shattuck Labs (STTK) report for Abhinav Shukla?

Abhinav A. Shukla, Chief Technical Officer, exercised stock options for 12,563 Common shares and sold 410 Common shares. The activity reflects option exercises plus a small related sale, all disclosed in a recent Form 4 filing.

At what prices did Abhinav Shukla transact Shattuck Labs (STTK) shares?

Shukla exercised options at an exercise price of $3.57 per share and sold 410 shares at a weighted average of $7.01. The sale occurred in multiple trades between $7.00 and $7.03 per share, according to the disclosure.

How many Shattuck Labs (STTK) shares does Abhinav Shukla hold after the Form 4 transactions?

After the reported transactions, Shukla holds 98,533 shares of Shattuck Labs Common Stock directly. He also retains 14,140 stock options with a $3.57 exercise price that are scheduled to expire on January 25, 2033, subject to vesting.

Was Abhinav Shukla’s sale of Shattuck Labs (STTK) shares pre-planned?

Yes. The filing states the 410-share sale was executed under a Rule 10b5-1 trading plan adopted on February 2, 2026. The plan is intended to sell shares only as needed to fund option exercise prices and estimated tax withholding obligations.

What is the purpose of Abhinav Shukla’s Rule 10b5-1 trading plan for Shattuck Labs (STTK)?

The Rule 10b5-1 plan aims to sell shares received from option exercises solely to cover exercise costs and estimated tax withholding. The footnote explains that once these obligations are fully funded, remaining exercised shares are held by Shukla rather than sold.

What are the key terms of Abhinav Shukla’s Shattuck Labs (STTK) stock option grant?

A referenced option covers 52,200 Common shares, with one quarter vesting on January 25, 2024 and the remaining three quarters vesting in equal monthly installments through January 25, 2027. Vesting requires Shukla’s continued service to Shattuck Labs.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shukla Abhinav A.

(Last)(First)(Middle)
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200

(Street)
AUSTIN TEXAS 78701

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Shattuck Labs, Inc. [ STTK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Technical Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/02/2026M410A$3.5786,790D
Common Stock07/02/2026S(1)410D$7.01(2)86,380D
Common Stock07/06/2026M12,153A$3.5798,533D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$3.5707/02/2026M410 (3)01/25/2033Common Stock410$0.0026,293D
Stock Option (Right to Buy)$3.5707/06/2026M12,153 (3)01/25/2033Common Stock12,153$0.0014,140D
Explanation of Responses:
1. Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026. The plan is intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding associated with option exercises under the plan. Under the procedures of the administering broker, acquired shares are first sold to fund the aggregate exercise price and estimated tax withholding with respect to all possible option exercises in a particular order under the plan and only once fully funded will acquired shares be held by the Reporting Person. This transaction represents the final sale of shares needed to fully fund the exercise price and estimated tax withholding for the option exercises under this order of the plan and the remaining shares acquired upon exercise under this order will be held by the Reporting Person.
2. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.000 to $7.030, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3. This option represents a right to purchase a total of 52,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
/s/ Andrew R. Neill, Attorney-in-fact for Abhinav A. Shukla07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)